Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Savita V, Dandapani"'
Autor:
Michael Reilly, Savita V. Dandapani, Kiran A. Kumar, Louis Constine, Shannon E. Fogh, Kenneth B. Roberts, William Small, Naomi R. Schechter
Publikováno v:
American Journal of Clinical Oncology. 46:185-192
Autor:
Jeffrey Y.C. Wong, David M. Yamauchi, Vikram Adhikarla, Jennifer Simpson, Paul H. Frankel, Yuman Fong, Kurt A. Melstrom, Yi-jen Chen, Behrooz D. Salehian, Yanghee Woo, Savita V. Dandapani, David M. Colcher, Erasmus K. Poku, Paul J. Yazaki, Anna M. Wu, John E. Shively
Publikováno v:
Cancer Biotherapy and Radiopharmaceuticals. 38:26-37
Autor:
Jeffrey Y C, Wong, David M, Yamauchi, Vikram, Adhikarla, Jennifer, Simpson, Paul H, Frankel, Yuman, Fong, Kurt A, Melstrom, Yi-Jen, Chen, Behrooz D, Salehian, Yanghee, Woo, Savita V, Dandapani, David M, Colcher, Erasmus K, Poku, Paul J, Yazaki, Anna M, Wu, John E, Shively
Publikováno v:
Cancer biotherapyradiopharmaceuticals.
Publikováno v:
The Scientific World Journal, Vol 2015 (2015)
Purpose. The study characterizes the impact of obesity on postoperative radiation-associated toxicities in women with endometrial cancer (EC). Material and Methods. A retrospective study identified 96 women with EC referred to a large urban instituti
Externí odkaz:
https://doaj.org/article/556bacdee4f14d57ba407235ca4658fd
Autor:
Zeynep Busra Zengin, Ameish Govindarajan, Ramya Muddasani, Nicholas Salgia, Nicolas Sayegh, Nishita Tripathi, Sabrina Salgia, Luis A Meza, Jiaming Zhang, Neal Shiv Chawla, Alex Chehrazi-Raffle, Jasnoor Malhotra, Nazli Dizman, Joann Hsu, Daniela V. Castro, Sara A. Byron, Savita V. Dandapani, Sumanta K. Pal
Publikováno v:
Journal of Clinical Oncology. 40:4555-4555
4555 Background: Addition of SBRT to systemic therapy in oligoprogressive mRCC has been shown to prolong the duration of systemic treatment (Cheung et al Eur Urol 2021; De et al BJUI 2021). To date, the genomic predictors of benefit are unknown. We h
Autor:
Ramya Muddasani, Ameish Govindarajan, Sabrina Salgia, Nicholas Salgia, Zeynep Busra Zengin, Luis A Meza, Joann Hsu, Alex Chehrazi-Raffle, Nazli Dizman, Neal Shiv Chawla, Jasnoor Malhotra, Cristiane Decat Bergerot, Errol James Philip, Daniela V. Castro, Savita V. Dandapani, Nishita Tripathi, Nicolas Sayegh, Sumanta K. Pal
Publikováno v:
Journal of Clinical Oncology. 40:336-336
336 Background: SBRT in indicated for the management of locally recurrent and oligometastatic mRCC as per National Comprehensive Cancer Network guidelines. Our study evaluates both the efficacy of radiotherapy (RT) in prolonging systemic treatment al
Autor:
Martin G. Sanda, Savita V. Dandapani
Publikováno v:
Seminars in Radiation Oncology. 18:67-72
Radical prostatectomy, external radiation therapy, and brachytherapy are all mainstay treatment options for clinically localized prostate cancer. Over time, each of these treatments has been modified so as to maximize percent cancer-free survival whi
Autor:
Robert J. Kolb, Raghu Kalluri, Martin R. Pollak, Savita V. Dandapani, Sumita Sinha, Benjamin D. Matthews, Robert E. Gerszten, Jing Zhou, Hikaru Sugimoto, Donald E. Ingber
Publikováno v:
Journal of Biological Chemistry. 282:467-477
Mutations in the alpha-actinin-4 gene ACTN4 cause an autosomal dominant human kidney disease. Mice deficient in alpha-actinin-4 develop a recessive phenotype characterized by kidney failure, proteinuria, glomerulosclerosis, and retraction of glomerul
Autor:
Savita V. Dandapani, Martin R. Pollak
Publikováno v:
Kidney International. 70:980-982
The list of known genes that, when altered, cause proteinuric renal disease continues to increase. Recent mouse and human genetic studies, including that by Hasselbacher et al., are refocusing our attention on glomerular basement membrane components